A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.

@article{ChalatValayer2011AFO,
  title={A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.},
  author={Emmanuelle Chal{\'e}at-Valayer and Bernard M. Parratte and Cyrille Colin and Ang{\'e}lique Denis and S{\'e}verine Oudin and Carole B{\'e}rard and J-C Bernard and V{\'e}ronique Bourg and B Deleplanque and I Dulieu and Philippe P Evrard and Paul Filipetti and Vincent Flurin and Philippe Gallien and B H{\'e}ron-Long and Isabelle Hodgkinson and Isabelle Husson and Isabelle Jaisson-Hot and Eric Maupas and Francesca A Meurin and Guy G Monnier and Dominique P{\'e}rennou and B Pialoux and V{\'e}ronique Quentin and Marion Simonetta Moreau and Muriel Schneider and Alain P. Yelnik and Philippe Marque},
  journal={European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society},
  year={2011},
  volume={15 5},
  pages={439-48}
}
BACKGROUND Dystonia and spasticity are common symptoms in children with Cerebral Palsy (CP), whose management is a challenge to overcome in order to enable the harmonized development of motor function during growth. AIM To describe botulinum toxin A (BTX-A) use and efficacy as a treatment of focal spasticity in CP children in France. METHODS This prospective observational study included 282 CP children mostly administered according to French standards with BTX-A in lower limbs. Realistic… CONTINUE READING